Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
BJU International
|
July 24, 2008
Low-risk localized prostate cancer: are we ready to tell patients that active surveillance is the preferred option?
Simon F Brewster
British Journal of Medical & Surgical Urology
|
June 20, 2012
PSA Velocity and Doubling Time in Diagnosis and Prognosis of Prostate Cancer
Andrew J Vickers, Simon F Brewster
BJU International
|
October 17, 2015
Urological recommendations from the National Institute for Health and Care Excellence (NICE) Guideline, June 2015: Suspected cancer: recognition and referral
Edward R Jefferies, Simon F Brewster,
BJU International
|
June 26, 2004
Genetics for urologists
Mark A Rochester, Simon F Brewster
BJU International
|
September 19, 2006
THE Wnt signalling pathway is a potential therapeutic target in prostate cancer
George W Yardy, Simon F Brewster
BJU International
|
April 2, 2014
NICE guidelines on Prostate Cancer Active Surveillance: is UK practice leading the world?
Edward H Streeter, Simon F Brewster,
Archivos Espanoles De Urologia
|
June 28, 2011
Prostate cancer: to screen or not to screen
Sarah-Jane V Bailey, Simon F Brewster
The Journal of Urology
|
January 12, 2005
A double-blind, randomized, controlled trial of topical glyceryl trinitrate for transrectal ultrasound guided prostate biopsy
Mark A Rochester, Karena LE Monnier, Simon F Brewster
European Urology Focus
|
November 4, 2017
Reducing Mortality in the Ageing Patient: Treatment of the Primary Tumour Is Not Necessary
Alastair D Lamb, Simon F Brewster, Freddie C Hamdy
BJU International
|
September 16, 2010
Serial analysis of resected prostate cancer suggests up-regulation of type 1 IGF receptor with disease progression
Benjamin W Turney, Gareth D H Turner, Simon F Brewster, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
BJU International
|
July 24, 2008
Low-risk localized prostate cancer: are we ready to tell patients that active surveillance is the preferred option?
Simon F Brewster
British Journal of Medical & Surgical Urology
|
June 20, 2012
PSA Velocity and Doubling Time in Diagnosis and Prognosis of Prostate Cancer
Andrew J Vickers, Simon F Brewster
BJU International
|
October 17, 2015
Urological recommendations from the National Institute for Health and Care Excellence (NICE) Guideline, June 2015: Suspected cancer: recognition and referral
Edward R Jefferies, Simon F Brewster,
BJU International
|
June 26, 2004
Genetics for urologists
Mark A Rochester, Simon F Brewster
BJU International
|
September 19, 2006
THE Wnt signalling pathway is a potential therapeutic target in prostate cancer
George W Yardy, Simon F Brewster
BJU International
|
April 2, 2014
NICE guidelines on Prostate Cancer Active Surveillance: is UK practice leading the world?
Edward H Streeter, Simon F Brewster,
Archivos Espanoles De Urologia
|
June 28, 2011
Prostate cancer: to screen or not to screen
Sarah-Jane V Bailey, Simon F Brewster
The Journal of Urology
|
January 12, 2005
A double-blind, randomized, controlled trial of topical glyceryl trinitrate for transrectal ultrasound guided prostate biopsy
Mark A Rochester, Karena LE Monnier, Simon F Brewster
European Urology Focus
|
November 4, 2017
Reducing Mortality in the Ageing Patient: Treatment of the Primary Tumour Is Not Necessary
Alastair D Lamb, Simon F Brewster, Freddie C Hamdy
BJU International
|
September 16, 2010
Serial analysis of resected prostate cancer suggests up-regulation of type 1 IGF receptor with disease progression
Benjamin W Turney, Gareth D H Turner, Simon F Brewster, et al.
Page
of 2